ABP/PPAR modulator 1
ABP/PPAR modulator 1 is an orally active FABP and PPAR multiple modulator (IC50s of 0.65 μM and 1.08 μM for FABP1 and FABP4, EC50 s of 9.19 μM, 2.20 μM and 1.58 μM for PPARα, PPARγ and PPARδ). ABP/PPAR modulator 1 has potent anti-metabolic dysfunction-associated steatohepatitis (MASH) activity. ABP/PPAR modulator 1 dose-dependently ameliorates multiple pathological characteristics of fatty liver in WD + Carbon tetrachloride-induced MASH mice model.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 3104894-76-7
- 分子式: C33H39NO7
- 分子量:561.67
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
|
PPARα 9.19 μM (EC50) |
PPARγ 2.20 μM (EC50) |
PPARδ 1.58 μM (EC50) |
FABP1 0.65 μM (IC50) |
FABP4 1.08 μM (IC50) |
ABP/PPAR modulator 1 (Compound 27) has superior binding capacity on PPARs (Kds of 5.23 μM, 0.98 μM and 0.76 μM for PPARα, PPARγ and PPARδ)[1].
ABP/PPAR modulator 1 (10 mM-0.1 μM) shows higher affinity for FABP1 than its endogenous ligand, linoleic acid (LA) (Kd: 5.885 μM vs. LA: 14.281 μM)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
ABP/PPAR modulator 1 (20 mg/kg, p.o., once a day for 4 weeks) significantly reduces TC and hepatic TG levels in MASH mice model[1].
ABP/PPAR modulator 1 (10 mg/kg, p.o., once a day for 4 weeks) significantly decreases the levels of liver LDH, serum AST, ALT, TBA, and TBIL, and does not affect the ALP level in MASH mice model[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:male C57BL/6 mice (6 weeks old) were given a high-sugar diet (18.9 g/L glucose and 23.1 g/L fructose) and a high-fat feed (41 % sucrose, 21.1 % fat, and 1.25 % cholesterol) with 2 % CCl4 olive oil (i.p., once a week for 12 weeks) to induce MASH
-
Dosage:5, 10, 20 mg/kg
-
Administration:p.o., once a day for 4 weeks, and then collects liver tissues.
-
Result:Dose-dependently reduced the liver weight, the liver weight to body weight ratio and NAS scores of MASH mice, with its anti-MASH efficacy significantly improving as the dosage increased.
Dose-dependently decreased MPO expression levels and downregulated MCP-1, TNF-α, IL-1β, and IL-6 mRNA expression in MASH mice model.
Significantly reduced the levels of liver of TC, hepatic TG levels liver LDH, serum AST, ALT, TBA, and TBIL, and did not affect the ALP level in MASH mice model.
Increased the levels of SOD, GSH-Px, and GST, and decreased MDA content, protecting the liver from oxidative stress in MASH mice model.
Significantly reduced the expression ofα-SMA, TGF-β and HYP levels, inhibiting the activation of hepatic stellate cells and the liver fibrosis in MASH mice model.
化学情報
-
CAS 番号 3104894-76-7
-
分子量 561.67
-
分子式 C33H39NO7
-
SMILES
COC1=CC=C(/C=C/C2=CC(OCC3=CC=C(OC(C)(C)C(N[C@@H](C(O)=O)CC(C)C)=O)C=C3)=CC(OC)=C2)C=C1
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
ABP/PPAR modulator 1 関連分類
HY-172883 関連分類
Powered by Bioz